WHO ICTRP trial
Bioequivalence study of salbutamol inhalation aerosol in healthy volunteers
ChiCTR1800014567 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800014567 |
|---|---|
| Public title | Bioequivalence study of salbutamol inhalation aerosol in healthy volunteers |
| Scientific title | A single dose, randomized, open label, crossover comparative bioequivalence study of salbutamol inhalation aerosol in healthy volunteers |
| Primary sponsor | Peking University First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Bronchial Asthma |
| Interventions | Experimental group:Albuterol aerosol inhaler, 100ug/puff under fasting, T2 puffs;Reference:Albuterol aerosol inhaler,100ug/puff under fasting R 2 puffs |
| Registration date | Jan 22, 2018 |
| Target size | Experimental group:21;Reference:21 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: